{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:07:08Z","timestamp":1777860428810,"version":"3.51.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11940-016-0405-6","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T09:43:18Z","timestamp":1458726198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Beh\u00e7et\u2019s Disease and Nervous System Involvement"],"prefix":"10.1007","volume":"18","author":[{"given":"Murat","family":"K\u00fcrt\u00fcnc\u00fc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsen","family":"Akman-Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"issue":"36","key":"405_CR1","first-page":"1152","volume":"105","author":"H Beh\u00e7et","year":"1937","unstructured":"Beh\u00e7et H. \u00dcber residivierende, apht\u00f6se durch ein Virus verursachtes Geschw\u00fcre am Mund, am Auge und an der Genitalien. Derm Wschr. 1937;105(36):1152\u201363.","journal-title":"Derm Wschr"},{"issue":"4","key":"405_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A G\u00fcl","year":"2015","unstructured":"G\u00fcl A. Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37(4):413\u20138. This is an excellent review that gives a comprehensive account of pathogenic factors involved in Beh\u00e7et\u2019s disease.","journal-title":"Semin Immunopathol"},{"issue":"3\u20134","key":"405_CR3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","volume":"32","author":"D Mendes","year":"2009","unstructured":"Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gon\u00e7alves O, et al. Beh\u00e7et\u2019s disease\u2014a contemporary review. J Autoimmun. 2009;32(3\u20134):178\u201388.","journal-title":"J Autoimmun"},{"issue":"5","key":"405_CR4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"S Yurdakul","year":"2008","unstructured":"Yurdakul S, Yazici H. Beh\u00e7et\u2019s syndrome. Best Pract Res Clin Rheumatol. 2008;22(5):793\u2013809.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"405_CR5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.berh.2011.05.002","volume":"25","author":"G Hatemi","year":"2011","unstructured":"Hatemi G, Yazici H. Beh\u00e7et\u2019s syndrome and micro-organisms. Best Pract Res Clin Rheumatol. 2011;25(3):389\u2013406.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"405_CR6","first-page":"912589","volume":"2012","author":"T\u0130 Kaya","year":"2012","unstructured":"Kaya T\u0130. Genetics of Beh\u00e7et\u2019s disease. Pathol Res Int. 2012;2012:912589.","journal-title":"Pathol Res Int"},{"issue":"4","key":"405_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clindermatol.2013.01.002","volume":"31","author":"C Mat","year":"2013","unstructured":"Mat C, Yurdakul S, Sevim A, \u00d6zyazgan Y, T\u00fcz\u00fcn Y. Beh\u00e7et\u2019s syndrome: facts and controversies. Clin Dermatol. 2013;31(4):352\u201361.","journal-title":"Clin Dermatol"},{"key":"405_CR8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/B978-0-7020-4088-7.00110-3","volume":"121","author":"S Saip","year":"2014","unstructured":"Saip S, Akman-Demir G, Siva A. Neuro-Beh\u00e7et syndrome. Handb Clin Neurol. 2014;121:1703\u201323.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"405_CR9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/jdv.12326","volume":"28","author":"D Cicek","year":"2014","unstructured":"Cicek D, Da\u011fl\u0131 AF, Aydin S, Baskaya Dogan F, Dertlio\u011flu SB, et al. Does hepcidin play a role in the pathogenesis of aphthae in Beh\u00e7et\u2019s disease and recurrent aphthous stomatitis? J Eur Acad Dermatol Venereol. 2014;28(11):1500\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1\u20132","key":"405_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jneuroim.2011.08.008","volume":"239","author":"B Vural","year":"2011","unstructured":"Vural B, U\u011furel E, T\u00fcz\u00fcn E, K\u00fcrt\u00fcnc\u00fc M, Zuliani L, Cavu\u015f F, et al. Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Beh\u00e7et\u2019s disease. J Neuroimmunol. 2011;239(1\u20132):91\u20137.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"405_CR11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3349\/ymj.1997.38.6.350","volume":"38","author":"T Sakane","year":"1997","unstructured":"Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Beh\u00e7et\u2019s disease: immunological aspects. Yonsei Med J. 1997;38(6):350\u20138.","journal-title":"Yonsei Med J"},{"issue":"7","key":"405_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2015.02.009","volume":"14","author":"M Marta","year":"2015","unstructured":"Marta M, Santos E, Coutinho E, Silva AM, Correia J, Vasconcelos C, et al. The role of infections in Beh\u00e7et disease and neuro-Beh\u00e7et syndrome. Autoimmun Rev. 2015;14(7):609\u201315.","journal-title":"Autoimmun Rev"},{"issue":"3 Suppl 77","key":"405_CR13","first-page":"32","volume":"31","author":"SY Na","year":"2013","unstructured":"Na SY, Park MJ, Park S, Lee ES. Up-regulation of Th17 and related cytokines in Beh\u00e7et\u2019s disease corresponding to disease activity. Clin Exp Rheumatol. 2013;31(3 Suppl 77):32\u201340.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"405_CR14","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar4570","volume":"16","author":"C Wang","year":"2014","unstructured":"Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P. Decreased interleukin 27 expression is associated with active uveitis in Beh\u00e7et\u2019s disease. Arthritis Res Ther. 2014;16(3):R117.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"405_CR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1566524014666140414210831","volume":"14","author":"Z Ye","year":"2014","unstructured":"Ye Z, Wang C, Kijlstra A, Zhou X, Yang P. A possible role for interleukin 37 in the pathogenesis of Behcet\u2019s disease. Curr Mol Med. 2014;14(4):535\u201342.","journal-title":"Curr Mol Med"},{"issue":"8","key":"405_CR16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et\u2019s disease. Nat Genet. 2010;42(8):698\u2013702. This is a genome-wide association study with over 300.000 SNP in 1215 patients with Beh\u00e7et\u2019s disease. This study underlines the importance of MHC class I region along with cytokine and cytokine receptor polymorphisms.","journal-title":"Nat Genet"},{"issue":"9","key":"405_CR17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","volume":"60","author":"M Zierhut","year":"2003","unstructured":"Zierhut M, Mizuki N, Ohno S, Inoko H, G\u00fcl A, Ono\u00e9 K, et al. Immunology and functional genomics of Beh\u00e7et\u2019s disease. Cell Mol Life Sci. 2003;60(9):1903\u201322.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"405_CR18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/08820139.2014.886260","volume":"43","author":"K Sakly","year":"2014","unstructured":"Sakly K, Lahmar R, Nefzi F, Hammami S, Harzallah O, Sakly N, et al. Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Beh\u00e7et\u2019s disease and association with HLA-B51 expression. Immunol Invest. 2014;43(5):463\u201378. This recent study provides an extensive list of peripheral blood immunophenotypes in association with disease activity in Beh\u00e7et\u2019s disease and emphasizes the significance of immune dysregulation in pathogenesis of Beh\u00e7et\u2019s disease.","journal-title":"Immunol Invest"},{"issue":"1\u20132","key":"405_CR19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Akman-Demir G, I\u015fik N, Serdaro\u011flu P. Cytokines and chemokines in neuro-Beh\u00e7et\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol. 2003;145(1\u20132):127\u201334.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"405_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","volume":"44","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, T\u00fcz\u00fcn E, I\u00e7\u00f6z S, Ye\u015filot N, Yent\u00fcr SP, K\u00fcrt\u00fcnc\u00fc M, et al. Interleukin-6 in neuro-Beh\u00e7et\u2019s disease: association with disease subsets and long-term outcome. Cytokine. 2008;44(3):373\u20136.","journal-title":"Cytokine"},{"issue":"1","key":"405_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","volume":"135","author":"I Kon\u00e9-Paut","year":"1999","unstructured":"Kon\u00e9-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, et al. Familial aggregation in Beh\u00e7et\u2019s disease: high frequency in siblings and parents of pediatric probands. J Pediatr. 1999;135(1):89\u201393.","journal-title":"J Pediatr"},{"issue":"10","key":"405_CR22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M Menthon de","year":"2009","unstructured":"de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case\u2013control genetic association studies. Arthritis Rheum. 2009;61(10):1287\u201396.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"405_CR23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/keq331","volume":"50","author":"M Piga","year":"2011","unstructured":"Piga M, Mathieu A. Genetic susceptibility to Behcet\u2019s disease: role of genes belonging to the MHC region. Rheumatology (Oxford). 2011;50(2):299\u2013310.","journal-title":"Rheumatology (Oxford)"},{"key":"405_CR24","first-page":"1913","volume":"19","author":"M Zhang","year":"2013","unstructured":"Zhang M, Xu WD, Wen PF, Liang Y, Liu J, Pan HF, et al. Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet\u2019s disease: an updated meta-analysis. Mol Vis. 2013;19:1913\u201324.","journal-title":"Mol Vis"},{"issue":"11\u201312","key":"405_CR25","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10528-013-9621-x","volume":"51","author":"L Vaccarino","year":"2013","unstructured":"Vaccarino L, Triolo G, Accardo-Palombo A, Scola L, Palmeri M, Bova M, et al. Pathological implications of Th1\/Th2 cytokine genetic variants in Beh\u00e7et\u2019s disease: data from a pilot study in a Sicilian population. Biochem Genet. 2013;51(11\u201312):967\u201375. This article gives a comprehensive account of the impact of cytokine gene polymorphisms on the risk of Beh\u00e7et\u2019s disease development.","journal-title":"Biochem Genet"},{"issue":"12","key":"405_CR26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00439-013-1346-8","volume":"132","author":"J Qi","year":"2013","unstructured":"Qi J, Hou S, Zhang Q, Liao D, Wei L, Fang J, et al. A functional variant of pre-miRNA-196a2 confers risk for Behcet\u2019s disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis. Hum Genet. 2013;132(12):1395\u2013404.","journal-title":"Hum Genet"},{"issue":"9","key":"405_CR27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00109-014-1159-9","volume":"92","author":"H Yu","year":"2014","unstructured":"Yu H, Liu Y, Bai L, Kijlstra A, Yang P. Predisposition to Beh\u00e7et\u2019s disease and VKH syndrome by genetic variants of miR-182. J Mol Med (Berl). 2014;92(9):961\u20137.","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"405_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1089\/gtmb.2015.0016","volume":"19","author":"T Oner","year":"2015","unstructured":"Oner T, Yenmis G, Tombulturk K, Cam C, Kucuk OS, Yakicier MC, et al. Association of pre-miRNA-499 rs3746444 and pre-miRNA-146a rs2910164 polymorphisms and susceptibility to Behcet\u2019s disease. Genet Test Mol Biomarkers. 2015;19(8):424\u201330.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8","key":"405_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"N Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet. 2010;42(8):703\u20136.","journal-title":"Nat Genet"},{"issue":"8","key":"405_CR30","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.34437","volume":"64","author":"JM Xavier","year":"2012","unstructured":"Xavier JM, Shahram F, Davatchi F, Rosa A, Crespo J, Abdollahi BS, et al. Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Beh\u00e7et\u2019s disease. Arthritis Rheum. 2012;64(8):2761\u201372.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"405_CR31","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tas\u00e7i B. Clinical patterns of neurological involvement in Beh\u00e7et\u2019s disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group. Brain. 1999;122(11):2171\u201382.","journal-title":"Brain"},{"issue":"2","key":"405_CR32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.nrl.0000156343.16797.c4","volume":"11","author":"A Borhani Haghighi","year":"2005","unstructured":"Borhani Haghighi A, Pourmand R, Nikseresht AR. Neuro-Beh\u00e7et disease. A review. Neurologist. 2005;11(2):80\u20139.","journal-title":"Neurologist"},{"issue":"2","key":"405_CR33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-2982.2005.01017.x","volume":"26","author":"E Aykutlu","year":"2006","unstructured":"Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M. Headache in Beh\u00e7et\u2019s disease. Cephalalgia. 2006;26(2):180\u20136.","journal-title":"Cephalalgia"},{"issue":"5","key":"405_CR34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","volume":"44","author":"E Seyahi","year":"2015","unstructured":"Seyahi E, Caglar E, Ugurlu S, Kantarci F, Hamuryudan V, Sonsuz A, et al. An outcome survey of 43 patients with Budd-Chiari syndrome due to Beh\u00e7et\u2019s syndrome followed up at a single, dedicated center. Semin Arthritis Rheum. 2015;44(5):602\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"405_CR35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0046-8177(85)80250-1","volume":"16","author":"S Lakhanpal","year":"1985","unstructured":"Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Beh\u00e7et\u2019s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16(8):790\u20135.","journal-title":"Hum Pathol"},{"issue":"7","key":"405_CR36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archneur.1996.00550070133022","volume":"53","author":"G Akman-Demir","year":"1996","unstructured":"Akman-Demir G, Baykan-Kurt B, Serdaroglu P, G\u00fcrvit H, Yurdakul S, Yazici H, et al. Seven-year follow-up of neurologic involvement in Beh\u00e7et syndrome. Arch Neurol. 1996;53(7):691\u20134.","journal-title":"Arch Neurol"},{"issue":"9","key":"405_CR37","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","volume":"261","author":"S Kalra","year":"2014","unstructured":"Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, et al. Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations. J Neurol. 2014;261(9):1662\u201376.","journal-title":"J Neurol"},{"issue":"5","key":"405_CR38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF00588368","volume":"35","author":"S Bahar","year":"1993","unstructured":"Bahar S, Coban O, G\u00fcrvit IH, Akman-Demir G, G\u00f6kyi\u011fit A. Spontaneous dissection of the extracranial vertebral artery with spinal subarachnoid haemorrhage in a patient with Beh\u00e7et\u2019s disease. Neuroradiology. 1993;35(5):352\u20134.","journal-title":"Neuroradiology"},{"issue":"6","key":"405_CR39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1468-1331.2001.00300.x","volume":"8","author":"Y Krespi","year":"2001","unstructured":"Krespi Y, Akman-Demir G, Poyraz M, Tugcu B, Coban O, Tuncay R, et al. Cerebral vasculitis and ischaemic stroke in Beh\u00e7et\u2019s disease: report of one case and review of the literature. Eur J Neurol. 2001;8(6):719\u201322.","journal-title":"Eur J Neurol"},{"issue":"2","key":"405_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s004150050317","volume":"246","author":"O Oktem-Tan\u00f6r","year":"1999","unstructured":"Oktem-Tan\u00f6r O, Baykan-Kurt B, G\u00fcrvit IH, Akman-Demir G, Serdaro\u011flu P. Neuropsychological follow-up of 12 patients with neuro-Beh\u00e7et disease. J Neurol. 1999;246(2):113\u20139.","journal-title":"J Neurol"},{"issue":"7","key":"405_CR41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-1331.2007.01754.x","volume":"14","author":"N Yesilot","year":"2007","unstructured":"Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G. Clinical characteristics and course of spinal cord involvement in Beh\u00e7et\u2019s disease. Eur J Neurol. 2007;14(7):729\u201337.","journal-title":"Eur J Neurol"},{"issue":"3 Suppl 77","key":"405_CR42","first-page":"88","volume":"31","author":"E Shugaiv","year":"2013","unstructured":"Shugaiv E, Kiyat-Atamer A, T\u00fcz\u00fcn E, Deymeer F, Oflazer P, Parman Y, et al. Coexistence of Guillain-Barr\u00e9 syndrome and Beh\u00e7et\u2019s disease. Clin Exp Rheumatol. 2013;31(3 Suppl 77):88\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"405_CR43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.clineuro.2009.07.009","volume":"111","author":"O Deniz","year":"2009","unstructured":"Deniz O, Cayk\u00f6yl\u00fc A, Vural G, Albayrak Y, Temel S, Aydin I, et al. A case study of neuro-psycho-Beh\u00e7et\u2019s syndrome presenting with psychotic attack. Clin Neurol Neurosurg. 2009;111(10):877\u20139.","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"405_CR44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.clineuro.2009.08.002","volume":"111","author":"M Mimura","year":"2009","unstructured":"Mimura M, Kato M, Kashima H. Neuro-Behcet\u2019s disease presenting with amnesia and frontal dysfunction. Clin Neurol Neurosurg. 2009;111(10):889\u201392.","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"405_CR45","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s10072-013-1304-1","volume":"34","author":"RS Calabr\u00f2","year":"2013","unstructured":"Calabr\u00f2 RS, Grugno R, Muscar\u00e0 N, Bramanti P. Pitfalls in the diagnosis of Neuro-Behcet presenting with psychiatric symptoms at onset: a case report! Neurol Sci. 2013;34(10):1827\u20138.","journal-title":"Neurol Sci"},{"issue":"7","key":"405_CR46","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/rheumatology\/ker449","volume":"51","author":"N Noel","year":"2012","unstructured":"Noel N, Huti\u00e9 M, Wechsler B, Vignes S, Le Thi H-BD, Amoura Z, et al. Pseudotumoural presentation of neuro-Behcet\u2019s disease: case series and review of literature. Rheumatology (Oxford). 2012;51(7):1216\u201325.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"405_CR47","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-004-0897-4","volume":"23","author":"R Kuriwaka","year":"2004","unstructured":"Kuriwaka R, Kunishige M, Nakahira H, Inoue H, Higashi T, Tokumoto Y, et al. Neuro-Beh\u00e7et\u2019s disease with chorea after remission of intestinal Beh\u00e7et\u2019s disease. Clin Rheumatol. 2004;23(4):364\u20137.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"405_CR48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mds.21834","volume":"23","author":"RC Gardner","year":"2008","unstructured":"Gardner RC, Schmahmann JD. Ataxia and cerebellar atrophy\u2014a novel manifestation of neuro-Beh\u00e7et disease? Mov Disord. 2008;23(2):307\u20138.","journal-title":"Mov Disord"},{"issue":"12","key":"405_CR49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00234-003-1102-1","volume":"45","author":"G Akman-Demir","year":"2003","unstructured":"Akman-Demir G, Bahar S, Coban O, Tasci B, Serdaroglu P. Cranial MRI in Behcet\u2019s disease: 134 MRI examinations of 98 patients. Neuroradiology. 2003;45(12):851\u20139.","journal-title":"Neuroradiology"},{"issue":"3 Suppl 77","key":"405_CR50","first-page":"25","volume":"31","author":"G Saruhan-Direskeneli","year":"2013","unstructured":"Saruhan-Direskeneli G, Yent\u00fcr SP, Mutlu M, Shugaiv E, Yesilot N, K\u00fcrt\u00fcnc\u00fc M, et al. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behcet\u2019s disease. Clin Exp Rheumatol. 2013;31(3 Suppl 77):25\u20137. This study underlines the significance of cerebrospinal fluid oligoclonal band detection in the differential diagnosis of neuro-Beh\u00e7et\u2019s disease and multiple sclerosis.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"405_CR51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002340050742","volume":"41","author":"O \u00c7oban","year":"1999","unstructured":"\u00c7oban O, Bahar S, Akman-Demir G, Serdaro\u011flu P, Baykan-Kurt B, Tolun R, et al. Masked assessment of MRI findings: is it possible to differentiate neuro-Beh\u00e7et\u2019s disease from other CNS diseases? Neuroradiology. 1999;41(4):255\u201360.","journal-title":"Neuroradiology"},{"issue":"7","key":"405_CR52","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","volume":"256","author":"N Yesilot","year":"2009","unstructured":"Yesilot N, Bahar S, Y\u0131lmazer S, Mutlu M, Kurtuncu M, Tuncay R, et al. Cerebral venous thrombosis in Behcet\u2019s disease compared to those associated with other etiologies. J Neurol. 2009;256(7):1134\u201342.","journal-title":"J Neurol"},{"issue":"21","key":"405_CR53","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.0b013e318238edeb","volume":"77","author":"D Uluduz","year":"2011","unstructured":"Uluduz D, K\u00fcrt\u00fcnc\u00fc M, Yap\u0131c\u0131 Z, Seyahi E, Kasap\u00e7opur \u00d6, \u00d6zdo\u011fan H, et al. Clinical characteristics of pediatric onset neuro-Behcet disease. Neurology. 2011;77(21):1900\u20135.","journal-title":"Neurology"},{"issue":"3","key":"405_CR54","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0161-6420(99)90120-3","volume":"106","author":"S Kotake","year":"1999","unstructured":"Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H. Central nervous system symptoms in patients with Beh\u00e7et disease receiving cyclosporine therapy. Ophthalmology. 1999;106(3):586\u20139.","journal-title":"Ophthalmology"},{"issue":"4 Suppl 50","key":"405_CR55","first-page":"S84","volume":"26","author":"G Akman-Demir","year":"2008","unstructured":"Akman-Demir G, Ayranci O, Kurtuncu M, Vanli EN, Mutlu M, Tugal-Tutkun I. Cyclosporine for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol. 2008;26(4 Suppl 50):S84\u201390.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"405_CR56","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/art.38351","volume":"66","author":"N Noel","year":"2014","unstructured":"Noel N, Bernard R, Wechsler B, Resche-Rigon M, Depaz R, Le Thi Huong Boutin D, et al. Long-term outcome of neuro-Beh\u00e7et\u2019s disease. Arthritis Rheumatol. 2014;66(5):1306\u201314. This study underlines the effect of HLA-B51 status on the long-term outcome of NBD patients suggesting a negative influence on the disease course.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"405_CR57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11940-011-0120-2","volume":"13","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Saip S, Siva A. Beh\u00e7et\u2019s disease. Curr Treat Options Neurol. 2011;13(3):290\u2013310.","journal-title":"Curr Treat Options Neurol"},{"issue":"4 Suppl 67","key":"405_CR58","first-page":"S64","volume":"29","author":"E Shugaiv","year":"2011","unstructured":"Shugaiv E, T\u00fcz\u00fcn E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et\u2019s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S64\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"405_CR59","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/0-306-48382-3_117","volume":"528","author":"H Kikuchi","year":"2003","unstructured":"Kikuchi H, Aramaki K, Hirohata S. Low dose MTX for progressive neuro-Beh\u00e7et\u2019s disease. A follow-up study for 4\u00a0years. Adv Exp Med Biol. 2003;528:575\u20138.","journal-title":"Adv Exp Med Biol"},{"issue":"1\u20132","key":"405_CR60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2015.01.005","volume":"349","author":"S Hirohata","year":"2015","unstructured":"Hirohata S, Kikuchi H, Sawada T, Nagafuchi H, Kuwana M, Takeno M, et al. Retrospective analysis of long-term outcome of chronic progressive neurological manifestations in Behcet\u2019s disease. J Neurol Sci. 2015;349(1\u20132):143\u20138.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"405_CR61","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S. Effect of infliximab in progressive neuro-Beh\u00e7et\u2019s syndrome. J Neurol Sci. 2008;272(1\u20132):99\u2013105. This is an interesting study implicating that the beneficial effect of infliximab may be through inhibition of IL-6 production.","journal-title":"J Neurol Sci"},{"issue":"12","key":"405_CR62","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00415-013-7150-5","volume":"260","author":"R Kuroda","year":"2013","unstructured":"Kuroda R, Suzuki J, Muramatsu M, Tasaki A, Yano M, Imai N, et al. Efficacy of infliximab in neuro-Beh\u00e7et\u2019s disease presenting with isolated longitudinally extensive transverse myelitis. J Neurol. 2013;260(12):3167\u201370.","journal-title":"J Neurol"},{"issue":"1\u20132","key":"405_CR63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jns.2014.09.052","volume":"347","author":"M Filippo Di","year":"2014","unstructured":"Di Filippo M, Di Gregorio M, Nannini C, Gaetani L, Gallina C, Floridi P, et al. Infliximab monotherapy for neuro-Beh\u00e7et\u2019s disease: a case report. J Neurol Sci. 2014;347(1\u20132):389\u201390.","journal-title":"J Neurol Sci"},{"issue":"8","key":"405_CR64","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/1346-8138.12203","volume":"40","author":"H Kanemaru","year":"2013","unstructured":"Kanemaru H, Makino T, Jinnin M, Yonemitsu A, Makino K, Ihn H. Case of neuro-Beh\u00e7et\u2019s disease successfully maintained a remission using infliximab for 2\u00a0years. J Dermatol. 2013;40(8):632\u20134.","journal-title":"J Dermatol"},{"issue":"4 Suppl 50","key":"405_CR65","first-page":"S133","volume":"26","author":"J Belzunegui","year":"2008","unstructured":"Belzunegui J, L\u00f3pez L, Paniagua I, Intxausti JJ, Ma\u00edz O. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Beh\u00e7et\u2019s disease. Clin Exp Rheumatol. 2008;26(4 Suppl 50):S133\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"405_CR66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clineuro.2006.11.002","volume":"109","author":"JE Alty","year":"2007","unstructured":"Alty JE, Monaghan TM, Bamford JM. A patient with neuro-Beh\u00e7et\u2019s disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Clin Neurol Neurosurg. 2007;109(3):279\u201381.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"405_CR67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pediatrneurol.2010.04.021","volume":"43","author":"AB Robinson","year":"2010","unstructured":"Robinson AB, Gallentine WB, Rabinovich CE. Pediatric neuro-Beh\u00e7et\u2019s disease responsive to adalimumab. Pediatr Neurol. 2010;43(4):291\u20133.","journal-title":"Pediatr Neurol"},{"issue":"4 Suppl 60","key":"405_CR68","first-page":"S102","volume":"28","author":"P Leccese","year":"2010","unstructured":"Leccese P, D\u2019Angelo S, Angela P, Coniglio G, Olivieri I. Switching to adalimumab is effective in a case of neuro-Behcet\u2019s disease refractory to infliximab. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S102.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"405_CR69","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","volume":"44","author":"O Addimanda","year":"2015","unstructured":"Addimanda O, Pipitone N, Pazzola G, Salvarani C. Tocilizumab for severe refractory neuro-Beh\u00e7et: three cases IL-6 blockade in neuro-Beh\u00e7et. Semin Arthritis Rheum. 2015;44(4):472\u20135.","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"405_CR70","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/rheumatology\/kev197","volume":"54","author":"I Pagnini","year":"2015","unstructured":"Pagnini I, Bondi T, Simonini G, Giani T, Marino A, Cimaz R. Successful treatment with canakinumab of a paediatric patient with resistant Beh\u00e7et\u2019s disease. Rheumatology (Oxford). 2015;54(7):1327\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"405_CR71","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-013-2443-8","volume":"34","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Vitale A, Scalini P, Dinarello CA, Rigante D, Franceschini R, et al. Anakinra treatment in drug-resistant Behcet\u2019s disease: a case series. Clin Rheumatol. 2015;34(7):1293\u2013301.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"405_CR72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00041327-200106000-00011","volume":"21","author":"JC Nichols","year":"2001","unstructured":"Nichols JC, Ince A, Akduman L, Mann ES. Interferon-alpha 2a treatment of neuro-Behcet disease. J Neuroophthalmol. 2001;21(2):109\u201311.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"405_CR73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/039463200702000110","volume":"20","author":"A Cata De","year":"2007","unstructured":"De Cata A, Intiso D, Bernal M, Molinaro F, Mazzoccoli G, D\u2019Alessandro V, et al. Prolonged remission of neuro-Behcet disease following autologous transplantation. Int J Immunopathol Pharmacol. 2007;20(1):91\u20136.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"405_CR74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jbspin.2005.01.012","volume":"73","author":"H Erdem","year":"2006","unstructured":"Erdem H, Din\u00e7 A, Pay S, Sim\u015fek I, Uysal Y. A neuro-Beh\u00e7et\u2019s case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt. Joint Bone Spine. 2006;73(2):200\u20131.","journal-title":"Joint Bone Spine"},{"issue":"9","key":"405_CR75","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s10620-012-2163-y","volume":"57","author":"K Wroblova","year":"2012","unstructured":"Wroblova K, Kolorz M, Batovsky M, Zboril V, Suchankova J, Bartos M, et al. Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients. Dig Dis Sci. 2012;57(9):2394\u2013401.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"405_CR76","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3349\/ymj.2015.56.4.1158","volume":"56","author":"JY Park","year":"2015","unstructured":"Park JY, Chung YR, Lee K, Song JH, Lee ES. Clinical experience of Interferon alfa-2a treatment for refractory uveitis in Beh\u00e7et\u2019s disease. Yonsei Med J. 2015;56(4):1158\u201362.","journal-title":"Yonsei Med J"},{"issue":"2","key":"405_CR77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1346-8138.12714","volume":"42","author":"E Chroni","year":"2015","unstructured":"Chroni E, Tsambaos D. Interferon-alpha for the treatment of severe entero- and neuro-Beh\u00e7et\u2019s disease. J Dermatol. 2015;42(2):229\u201330.","journal-title":"J Dermatol"},{"issue":"4","key":"405_CR78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1157\/13117047","volume":"208","author":"A Riera-Mestre","year":"2008","unstructured":"Riera-Mestre A, Mart\u00ednez-Y\u00e9lamos S, Mart\u00ednez-Y\u00e9lamos A, Vidaller A, Pujol R. Neuro-Beh\u00e7et and neurotoxicity due to cyclosporine. Rev Clin Esp. 2008;208(4):205\u20136.","journal-title":"Rev Clin Esp"},{"issue":"5","key":"405_CR79","first-page":"930","volume":"35","author":"I Olivieri","year":"2008","unstructured":"Olivieri I, Latanza L, Siringo S, Peruz G, Di Iorio V. Successful treatment of severe Beh\u00e7et\u2019s disease with infliximab in an Italian Olympic athlete. J Rheumatol. 2008;35(5):930\u20132.","journal-title":"J Rheumatol"},{"issue":"12","key":"405_CR80","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2169\/internalmedicine.54.4274","volume":"54","author":"I Kurata","year":"2015","unstructured":"Kurata I, Tsuboi H, Takahashi H, Abe S, Ebe H, Hagiwara S, et al. Successful treatment with infliximab for refractory uveitis in a hemodialysis patient with Beh\u00e7et\u2019s disease and a review of the literature for infliximab use in patients on hemodialysis. Intern Med. 2015;54(12):1553\u20137.","journal-title":"Intern Med"},{"issue":"3","key":"405_CR81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12013-014-9860-4","volume":"69","author":"D Ma","year":"2014","unstructured":"Ma D, Zhang CJ, Wang RP, Wang L, Yang H. Etanercept in the treatment of intestinal Behcet\u2019s disease. Cell Biochem Biophys. 2014;69(3):735\u20139.","journal-title":"Cell Biochem Biophys"},{"issue":"5","key":"405_CR82","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cgh.2014.08.042","volume":"13","author":"S Tanida","year":"2015","unstructured":"Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, et al. Adalimumab for the treatment of Japanese patients with intestinal Beh\u00e7et\u2019s disease. Clin Gastroenterol Hepatol. 2015;13(5):940\u20138.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 7","key":"405_CR83","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.4103\/0378-6323.115526","volume":"79","author":"S Dogra","year":"2013","unstructured":"Dogra S, Khullar G. Tumor necrosis factor-\u03b1 antagonists: side effects and their management. Indian J Dermatol Venereol Leprol. 2013;79 Suppl 7:S35\u201346.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"405_CR84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000358125","volume":"228","author":"A Vitale","year":"2014","unstructured":"Vitale A, Rigante D, Caso F, Brizi MG, Galeazzi M, Costa L, et al. Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Beh\u00e7et\u2019s disease: a case series. Dermatology. 2014;228(3):211\u20134.","journal-title":"Dermatology"},{"issue":"3 Suppl 72","key":"405_CR85","first-page":"S73","volume":"30","author":"P Urbaniak","year":"2012","unstructured":"Urbaniak P, Hasler P, Kretzschmar S. Refractory neuro-Beh\u00e7et treated by tocilizumab: a case report. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S73\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"405_CR86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","volume":"114","author":"LS Shapiro","year":"2012","unstructured":"Shapiro LS, Farrell J, Borhani Haghighi A. Tocilizumab treatment for neuro-Behcet\u2019s disease, the first report. Clin Neurol Neurosurg. 2012;114(3):297\u20138.","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"405_CR87","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10067-013-2471-4","volume":"33","author":"S Li","year":"2014","unstructured":"Li S. Analysis of 27 cases of large vascular lesions in 161 cases of Behcet\u2019s disease: clinical manifestations and treatment outcome. Clin Rheumatol. 2014;33(5):671\u20135.","journal-title":"Clin Rheumatol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0405-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-016-0405-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0405-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:05:24Z","timestamp":1559437524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-016-0405-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s11940-016-0405-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]},"article-number":"19"}}